Andreia Machado Leopoldino

13PUBLICATIONS
38CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 01, 2026
miR-205 Enhances Sensitivity to Genotoxic Agents in HNSCC Cells and Blocks Sphingosine Kinase 2 Action in Tumorigenicity.

Thaís Moré Milan, Gabriel da Silva, Graziella Ribeiro de Sousa

|Dec 24, 2025
High level of KMT5C is associated to better prognosis and its knockdown increases proliferation in head and neck cancer.

Lucas Oliveira Sousa, Gabriel da Silva, Thaís Moré Milan

|Nov 27, 2024
SIGMAR1 Knockdown Enhances Oral Cancer Cell Chemosensitivity to Cisplatin via Decreased PD-L1 Expression.

Pablo Shimaoka Chagas, Cristiana Bernadelli Garcia, Lucas Oliveira Sousa

|Dec 22, 2023
SET protein as an epigenetics target.

Gabriel da Silva, Thaís Moré Milan, Pablo Shimaoka Chagas

|Nov 10, 2023
FTY720 increases paclitaxel efficacy in cisplatin-resistant oral squamous cell carcinoma.

Lizeth Andrea Torres Torres, Gabriel Silva, Jovelina Samara Ferreira Alves

Pageof 3